The Discounted Cash Flow (DCF) valuation of Boston Scientific Corp (BSX) is 71.04 USD. With the latest stock price at 62.82 USD, the upside of Boston Scientific Corp based on DCF is 13.1%.
Based on the latest price of 62.82 USD and our DCF valuation, Boston Scientific Corp (BSX) is a buy. buying BSX stocks now will result in a potential gain of 13.1%.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 8.2% | 7.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 44.97 - 162.22 | 71.04 |
| Upside | -28.4% - 158.2% | 13.1% |